Inogen (INGN) Competitors $7.24 -0.18 (-2.43%) As of 07/3/2025 03:48 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INGN vs. SIBN, BBNX, CBLL, EMBC, AVNS, RXST, BVS, BFLY, KIDS, and SMLRShould you be buying Inogen stock or one of its competitors? The main competitors of Inogen include SiBone (SIBN), Beta Bionics (BBNX), CeriBell (CBLL), Embecta (EMBC), Avanos Medical (AVNS), RxSight (RXST), Bioventus (BVS), Butterfly Network (BFLY), OrthoPediatrics (KIDS), and Semler Scientific (SMLR). These companies are all part of the "medical equipment" industry. Inogen vs. Its Competitors SiBone Beta Bionics CeriBell Embecta Avanos Medical RxSight Bioventus Butterfly Network OrthoPediatrics Semler Scientific Inogen (NASDAQ:INGN) and SiBone (NASDAQ:SIBN) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings, analyst recommendations and media sentiment. Does the media refer more to INGN or SIBN? In the previous week, Inogen and Inogen both had 1 articles in the media. SiBone's average media sentiment score of 1.89 beat Inogen's score of 0.75 indicating that SiBone is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inogen 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SiBone 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is INGN or SIBN more profitable? Inogen has a net margin of -8.08% compared to SiBone's net margin of -15.03%. Inogen's return on equity of -14.76% beat SiBone's return on equity.Company Net Margins Return on Equity Return on Assets Inogen-8.08% -14.76% -9.01% SiBone -15.03%-16.00%-11.69% Do analysts recommend INGN or SIBN? Inogen currently has a consensus price target of $11.00, indicating a potential upside of 51.93%. SiBone has a consensus price target of $22.50, indicating a potential upside of 21.89%. Given Inogen's higher possible upside, equities analysts plainly believe Inogen is more favorable than SiBone.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inogen 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50SiBone 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders believe in INGN or SIBN? 89.9% of Inogen shares are owned by institutional investors. Comparatively, 98.1% of SiBone shares are owned by institutional investors. 1.5% of Inogen shares are owned by insiders. Comparatively, 4.0% of SiBone shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has higher valuation and earnings, INGN or SIBN? SiBone has lower revenue, but higher earnings than Inogen. SiBone is trading at a lower price-to-earnings ratio than Inogen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInogen$339.96M0.57-$35.89M-$1.15-6.30SiBone$167.18M4.71-$30.91M-$0.64-28.84 Which has more volatility & risk, INGN or SIBN? Inogen has a beta of 1.66, meaning that its share price is 66% more volatile than the S&P 500. Comparatively, SiBone has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500. SummarySiBone beats Inogen on 8 of the 15 factors compared between the two stocks. Get Inogen News Delivered to You Automatically Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INGN vs. The Competition Export to ExcelMetricInogenMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$201.38M$6.86B$5.53B$9.05BDividend YieldN/A1.21%5.24%4.03%P/E Ratio-6.3026.1527.5220.22Price / Sales0.5799.70421.02118.64Price / CashN/A21.0936.8958.07Price / Book0.994.748.045.67Net Income-$35.89M$173.18M$3.18B$249.13M7 Day Performance2.26%1.33%2.90%3.28%1 Month Performance14.92%0.16%3.70%5.55%1 Year Performance-12.24%23.71%36.15%21.12% Inogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INGNInogen4.4114 of 5 stars$7.24-2.4%$11.00+51.9%-10.4%$201.38M$339.96M-6.301,030SIBNSiBone4.1696 of 5 stars$16.52+0.8%$22.50+36.2%+41.6%$704M$176.60M-25.81350BBNXBeta BionicsN/A$15.80-11.7%$23.44+48.4%N/A$685.09M$65.12M0.00294Gap UpCBLLCeriBell2.1033 of 5 stars$18.49+3.2%$32.50+75.8%N/A$668.23M$65.44M0.00N/AEMBCEmbecta4.278 of 5 stars$9.82+0.5%$19.33+96.9%-14.5%$573.88M$1.12B10.912,100AVNSAvanos MedicalN/A$12.09-0.4%N/A-36.4%$559.09M$689.20M-1.442,227RXSTRxSight1.7709 of 5 stars$13.54-0.5%$37.90+179.9%-76.8%$550.27M$139.93M-20.21220News CoverageBVSBioventus2.7289 of 5 stars$6.52-0.5%$14.33+119.8%+21.3%$535.58M$567.70M-10.691,200Positive NewsBFLYButterfly Network2.4822 of 5 stars$2.05-1.4%$4.00+95.1%+100.8%$506.94M$82.06M-7.07460News CoverageAnalyst ForecastKIDSOrthoPediatrics4.2242 of 5 stars$20.59+1.5%$35.83+74.0%-25.0%$500.13M$204.73M-11.77200SMLRSemler Scientific1.8389 of 5 stars$41.99+16.2%$71.00+69.1%+21.7%$468.27M$49.23M-16.09120High Trading Volume Related Companies and Tools Related Companies SiBone Alternatives Beta Bionics Alternatives CeriBell Alternatives Embecta Alternatives Avanos Medical Alternatives RxSight Alternatives Bioventus Alternatives Butterfly Network Alternatives OrthoPediatrics Alternatives Semler Scientific Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INGN) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inogen, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Inogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INGN Stock Alerts